LPL Financial LLC - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$113,281
-30.7%
96,000
-17.2%
0.00%
Q2 2023$163,561
-16.1%
116,000
-10.8%
0.00%
Q1 2023$195,062
+10.7%
130,041
-13.6%
0.00%
Q4 2022$176,150
-17.7%
150,555
-20.5%
0.00%
Q3 2022$214,000
-43.4%
189,320
-20.9%
0.00%
Q2 2022$378,000
+56.2%
239,320
+52.6%
0.00%
Q1 2022$242,000
-10.0%
156,830
+42.8%
0.00%
Q4 2021$269,000
+21.7%
109,791
+25.4%
0.00%
Q3 2021$221,000
+28.5%
87,580
+45.0%
0.00%
Q2 2021$172,000
+53.6%
60,380
+26.8%
0.00%
Q1 2021$112,000
+154.5%
47,634
+90.0%
0.00%
Q4 2020$44,000
+91.3%
25,073
+4.2%
0.00%
Q3 2020$23,000
+4.5%
24,059
-6.2%
0.00%
Q2 2020$22,000
+69.2%
25,649
+64.2%
0.00%
Q1 2020$13,000
-13.3%
15,625
-9.8%
0.00%
Q4 2019$15,000
-11.8%
17,314
-2.2%
0.00%
Q3 2019$17,00017,7020.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Defender Capital, LLC. 4,735,990$8,335,0003.63%
BROADWOOD CAPITAL INC 34,005,379$59,849,0003.55%
Prescott General Partners LLC 1,851,851$3,259,0000.14%
Strategic Wealth Investment Group, LLC 66,917$118,0000.07%
Laidlaw Wealth Management LLC 170,658$300,0000.06%
Humankind Investments LLC 26,737$47,0000.05%
DAFNA Capital Management LLC 80,000$141,0000.04%
Beirne Wealth Consulting Services, LLC 45,000$79,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 680,839$1,198,0000.02%
Allegheny Financial Group LTD 20,000$35,0000.02%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders